Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1784275 | 0.81 | PTPN1 (0.33) | SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1782615 | 0.80 | SLC1A3 (0.35) | SLC1A3SLC1A2SLC1A1ALDH1A1TDP1 | |
| SCHEMBL1784785 | 0.79 | SLC1A3 (0.38) | SLC1A3SLC1A2SLC1A1ALDH1A1CPA1 | |
| SCHEMBL1782784 | 0.76 | METAP1 (0.36) | SLC1A3SLC1A2SLC1A1TDP1TSHR | |
| SCHEMBL1782165 | 0.72 | CA2 (0.41) | SLC1A3SLC1A2SLC1A1ALDH1A1TDP1 | |
| SCHEMBL13611203 | 0.72 | — | — | |
| SCHEMBL15116682 | 0.72 | — | — | |
| SCHEMBL13039796 | 0.72 | SLC1A3 (0.39) | SLC1A3SLC1A2SLC1A1ALDH1A1TSHR | |
| SCHEMBL14560234 | 0.71 | LAP3 (0.36) | SLC1A3SLC1A2KISS1RALDH1A1RNPEP | |
| SCHEMBL1781745 | 0.71 | LAP3 (0.36) | SLC1A3SLC1A2KISS1RALDH1A1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | SLC1A3 4740/4885SLC1A2 4505/4885SLC1A1 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.